RPLND or Primary Chemotherapy in Clinical Stage IIA/B Nonseminomatous Germ Cell Tumors?

The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology

N.K. Aaronson, Sam H. Ahmedzai, Bengt Bergman et al. · JNCI Journal of the National Cancer Institute · 1993 · 16K citations

Pharmacy, Oncology, Cancer Symptom Management +15

Risk of Second Malignant Neoplasms Among Long-term Survivors of Testicular Cancer

L. B. Travis, Rochelle E. Curtis, Joseph F. Fraumeni et al. · JNCI Journal of the National Cancer Institute · 1997 · 494 citations

Medicine, Oncology, Cancer Epidemiology +14

Immediate Adjuvant Chemotherapy versus Observation with Treatment at Relapse in Pathological Stage II Testicular Cancer

Stephen D. Williams, Donald M. Stablein, Lawrence H. Einhorn et al. · New England Journal of Medicine · 1987 · 391 citations

Medicine, Oncology, Cancer Control +10

Short-course adjuvant chemotherapy in high-risk stage I nonseminomatous germ cell tumors of the testis: a Medical Research Council report.

M.H. Cullen, Sally Stenning, M C Parkinson et al. · Journal of Clinical Oncology · 1996 · 319 citations

Medicine, Oncology, Pathology +16

Fertility after chemotherapy for testicular germ cell cancers.

Hans Lampe, A. Horwich, A. Norman et al. · Journal of Clinical Oncology · 1997 · 298 citations

Medicine, Oncology, Fertility +8